1 / 1

Acute venous or arterial thrombosis

Vanderbilt Pediatric Hematology Thrombolysis ( tPA ) Protocol . Robert F. Sidonio, Jr. MD, MSc . . 4 / 1 /12. Catheter-directed tPA 1) Contact Interventional Radiology for catheter-directed tPA 2) Start therapeutic UFH gtt 3) Make NPO for procedure 4) Start mIVF

burt
Download Presentation

Acute venous or arterial thrombosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vanderbilt Pediatric Hematology Thrombolysis (tPA) Protocol Robert F. Sidonio, Jr. MD, MSc. 4/1/12 Catheter-directed tPA 1) Contact Interventional Radiology for catheter-directed tPA 2) Start therapeutic UFH gtt 3) Make NPO for procedure 4) Start mIVF 5) Lab goals: Platelet >100k Fibrinogen >100mg/dL 6) CTA/V of affected area prior to catheter-directed tPA 7) Once catheter tPA done: a) Goal PTT 65-100 seconds x 48hrs b) Check tPA labs q8h x 48 hrs c) Convert to Enoxaparin after 48hrs Yes Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral or IVC DVT?____________________________________ Consider anatomic thrombotic obstruction: May-Thurner Syndrome -Acute occlusive iliofemoral vein/lower IVC thrombosis in left lower extremity Paget-Schroetter Syndrome -Subclavian thrombosis with recent vigorous exercise of upper extremity (pitcher, drummer, etc.) Yes Acute venous or arterial thrombosis Check baseline tPA labs: CBC PT/PTT Fibrinogen activity Plasminogen activity D-dimer (quantitative) FVIII activity CMP CRP Yes Obtain pediatric hematology consult Does patient meet inclusion and exclusion criteria for tPA? • Systemic tPA • 1) Begin systemic tPA: • - 0.06mg/kg/hr if <2 months of age • - 0.03mg/kg/hr if >2 months of age • 2) Perform cranial U/S if <1 month old within 7days • 3) Concurrent UFH gtt at 10 Units/kg/hr • Do not adjust PTT to therapeutic goal • 4) tPA labs q8hrs • 5) Maintain fibrinogen and plt count >100 • 6) tPAx 24 hours and re-image with U/S Is there an indication for thrombolysis? No No No Baseline labs: CBC, PT, PTT, fibrinogen activity, FVIII activity, D-dimer (quantitative) and CRP -Defer hypercoaguability workup until outpatient -Start UFH or Enoxaparin _____________________________________________ Start Enoxaparin: <3 month old 1.7mg/kg/dose BID 3-12 months old 1.5mg/kg/dose BID 1-5 years old 1.2mg/kg/dose BID 6-18 years of age 1mg/kg/dose BID -Notify Kathy Jernigan for teaching (pager 831-6629) Goal anti-Fxa 0.5-1, 4-5 hours after second dose ____________________________________________ UFH (clinically unstable, expected surgery or post-cardiac surgery) : Load: 75 units/kg over 10 minutes (max 5000 units) Maintenance: < 1 year of age: 28 units/kg/hr ≥ 1 year of age: 20 units/kg/dose Goal PTT 65-100 seconds (Consider only 24-72 hrs) and anti-FXa inhibition 0.35-0.7 Indications for thrombolysis Strong Indications -Life, limb or organ-threatening thrombosis -Arterial or venous thrombosis causing ischemia -Superior Vena Cava Syndrome -Massive PE with cardio instability -Bilateral renal vein thrombosis -Cerebral Sinovenous thrombosis with neurologic decline -Large atrial thrombi (congenital heart disease) Intermediate Indications -Acute iliofemoral or IVC thrombosis -May-Thurner Syndrome -Paget-Schroetter Syndrome >0-50% clot lysis Increase tPA by 50% Repeat U/S in 24hrs >95% clot lysis Stop tPA -Therapeutic UFH x 48 hrs - tPA labs x 48hrs -Switch to Enoxaparin No clot lysis Double tPA dose Repeat U/S in 24hrs >50-95% clot lysis Cont. same dose tPA Repeat U/S in 24hrs 0-50% clot lysis Either the following: -Continue same tPA dose and repeat U/S in 24hrs -Stop tPA __________________________________________ Once tPA done: Therapeutic UFH x 48 hrs, tPA labs x 48hrs Switch to Enoxaparin >50-100% clot lysis Either the following: -Continue same tPA dose and repeat U/S in 24hrs -Stop tPA ________________________________________ Once tPA done: Therapeutic UFH x 48 hrs, tPA labs x 48hrs Switch to Enoxaparin • Inclusion Criteria for tPA • -Symptoms present <14 days • -Thrombus site and extent confirmed by objective imaging • -No more than 48 hours of UFH • or LMWH for thrombus (systemic tPA only) • -Platelet count > 100,000/l • -Fibrinogen > 100 mg/dl • -No thrombus in previous site • Exclusion criteria for tPA • -Active bleeding • -Active seizures < 48 hours • -Invasive procedure < 3 days • (chest tube, lumbar puncture, liver biopsy etc) • -Major surgery < 10 days • -CNS bleeding or surgery < 14 days • -History of HIT • -Allergic reaction to UFH, LMWH or alteplase • -Renal or liver failure • -Uncontrolled Hypertension tPA labs CBC PT/PTT Fibrinogen activity D-dimer (quantitative) BMP -CMP if LFTS abnormal at baseline Key UFH: Unfractionated Heparin LMWH: Low molecular weight Heparin CNS: Central Nervous System tPA: Tissue Plasminogen Activator (usually alteplase) Gtt: drip HIT: Heparin induced thrombocytopenia

More Related